Search research articles
Contact Us
Filters
Showing results (1061-1070 of 1,095) with videos related to
Page
of 110
Sort By:
European Urology Oncology
|
July 22, 2023
Real-world Outcome of Patients with Advanced Renal Cell Carcinoma and Intermediate- or Poor-risk International Metastatic Renal Cell Carcinoma Database Consortium Criteria Treated by Immune-oncology Combinations: Differential Effectiveness by Risk Group?
Matteo Santoni, Sebastiano Buti, Zin W Myint, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 2, 2021
Predictive ability of a drug-based score in patients with advanced non-small-cell lung cancer receiving first-line immunotherapy
Sebastiano Buti, Melissa Bersanelli, Fabiana Perrone, et al.
Minerva Urology and Nephrology
|
August 2, 2023
Geographical differences in the management of metastatic de novo renal cell carcinoma in the era of immune-combinations
Camillo Porta, Aristotelis Bamias, Roubini Zakopoulou, et al.
Eclinicalmedicine
|
July 12, 2023
Impact of influenza vaccination on survival of patients with advanced cancer receiving immune checkpoint inhibitors (INVIDIa-2): final results of the multicentre, prospective, observational study
Melissa Bersanelli, Elena Verzoni, Alessio Cortellini, et al.
The Oncologist
|
May 20, 2026
Refining Prognosis in Advanced Renal Cell Carcinoma: International Real-World Validation of the Meet-URO Score in First-Line Immunotherapy Combinations
Sara Elena Rebuzzi, Aruni Ghose, Sarah Rudman, et al.
Journal of Hepatology
|
June 21, 2024
Sex and ethnic disparities in hepatitis B evaluation and treatment across the world
Sahith Kudaravalli, Daniel Q Huang, Ming-Lun Yeh, et al.
Journal of Personalized Medicine
|
May 28, 2022
Validation of a Novel Three-Dimensional (<i>3D Fusion</i>) Gross Sampling Protocol for Clear Cell Renal Cell Carcinoma to Overcome Intratumoral Heterogeneity: The Meet-Uro 18 Study
Matteo Brunelli, Guido Martignoni, Giorgio Malpeli, et al.
Cancer Immunology, Immunotherapy : CII
|
June 1, 2020
Clinicopathologic correlates of first-line pembrolizumab effectiveness in patients with advanced NSCLC and a PD-L1 expression of ≥ 50
Alessio Cortellini, Marcello Tiseo, Giuseppe L Banna, et al.
Lung Cancer (Amsterdam, Netherlands)
|
December 15, 2010
Italian Survey on adjuvant treatment of non-small cell lung cancer (ISA)
Giuseppe Luigi Banna, Massimo Di Maio, Alessandro Follador, et al.
Therapeutic Advances in Medical Oncology
|
November 23, 2020
Symptomatic COVID-19 in advanced-cancer patients treated with immune-checkpoint inhibitors: prospective analysis from a multicentre observational trial by FICOG
Melissa Bersanelli, Diana Giannarelli, Ugo De Giorgi, et al.
Page
of 110
Search research articles
Search
Showing results (1061-1070 of 1,095) with videos related to
Sort By:
Page
of 110
European Urology Oncology
|
July 22, 2023
Real-world Outcome of Patients with Advanced Renal Cell Carcinoma and Intermediate- or Poor-risk International Metastatic Renal Cell Carcinoma Database Consortium Criteria Treated by Immune-oncology Combinations: Differential Effectiveness by Risk Group?
Matteo Santoni, Sebastiano Buti, Zin W Myint, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 2, 2021
Predictive ability of a drug-based score in patients with advanced non-small-cell lung cancer receiving first-line immunotherapy
Sebastiano Buti, Melissa Bersanelli, Fabiana Perrone, et al.
Minerva Urology and Nephrology
|
August 2, 2023
Geographical differences in the management of metastatic de novo renal cell carcinoma in the era of immune-combinations
Camillo Porta, Aristotelis Bamias, Roubini Zakopoulou, et al.
Eclinicalmedicine
|
July 12, 2023
Impact of influenza vaccination on survival of patients with advanced cancer receiving immune checkpoint inhibitors (INVIDIa-2): final results of the multicentre, prospective, observational study
Melissa Bersanelli, Elena Verzoni, Alessio Cortellini, et al.
The Oncologist
|
May 20, 2026
Refining Prognosis in Advanced Renal Cell Carcinoma: International Real-World Validation of the Meet-URO Score in First-Line Immunotherapy Combinations
Sara Elena Rebuzzi, Aruni Ghose, Sarah Rudman, et al.
Journal of Hepatology
|
June 21, 2024
Sex and ethnic disparities in hepatitis B evaluation and treatment across the world
Sahith Kudaravalli, Daniel Q Huang, Ming-Lun Yeh, et al.
Journal of Personalized Medicine
|
May 28, 2022
Validation of a Novel Three-Dimensional (<i>3D Fusion</i>) Gross Sampling Protocol for Clear Cell Renal Cell Carcinoma to Overcome Intratumoral Heterogeneity: The Meet-Uro 18 Study
Matteo Brunelli, Guido Martignoni, Giorgio Malpeli, et al.
Cancer Immunology, Immunotherapy : CII
|
June 1, 2020
Clinicopathologic correlates of first-line pembrolizumab effectiveness in patients with advanced NSCLC and a PD-L1 expression of ≥ 50
Alessio Cortellini, Marcello Tiseo, Giuseppe L Banna, et al.
Lung Cancer (Amsterdam, Netherlands)
|
December 15, 2010
Italian Survey on adjuvant treatment of non-small cell lung cancer (ISA)
Giuseppe Luigi Banna, Massimo Di Maio, Alessandro Follador, et al.
Therapeutic Advances in Medical Oncology
|
November 23, 2020
Symptomatic COVID-19 in advanced-cancer patients treated with immune-checkpoint inhibitors: prospective analysis from a multicentre observational trial by FICOG
Melissa Bersanelli, Diana Giannarelli, Ugo De Giorgi, et al.
Page
of 110